Andrews Patricia S 4

What Happened
Patricia S. Andrews, a director of Oncolytics Biotech Inc. (ONCY), made open-market purchases of 35,400 shares on February 12, 2026. The weighted-average price reported was $0.86 per share (individual trades ranged $0.8483–$0.86), for a total reported cost of $30,292. This was a purchase (transaction code P), which is a direct acquisition of stock rather than a sale or option exercise.

Key Details

• Transaction date: 2026-02-12; Form filed: 2026-02-13 (timely filing).
• Price: weighted average $0.86; reported per-share range $0.8483–$0.86.
• Shares acquired: 35,400; total reported value: $30,292.
• Shares owned after the transaction: not stated in the provided filing.
• Footnote: F1 — the $0.86 is a weighted average; the reporting person can provide exact counts at each price on request.
• Transaction type: P (open-market purchase).

Context
This was a straightforward open-market buy (not an option exercise, award, or gift). The purchase amount is relatively modest (~$30k), so while purchases are generally viewed as a more informative insider signal than sales, the dollar size here is small. Retail investors should note the facts above and consider this alongside other insider activity and company fundamentals.